2024. Efficacy and safety of secukinumab in the treatment of chronic plaque psoriasis: A 52-weeks follow up study. Journal of Pakistan Association of Dermatologists. 34, 1 (May 2024), 191–199. DOI:https://doi.org/10.66344/jpad.v34i1.2545.